Franck Rouby
Impact in
-
- Cancer Immunotherapy and Biomarkers
- CAR-T cell therapy research
- Colorectal Cancer Treatments and Studies
- Pancreatic and Hepatic Oncology Research
Papers in
- Oncology 7
- Cancer Immunotherapy and Biomarkers 6
- Colorectal Cancer Treatments and Studies 2
-
- Immunodeficiency and Autoimmune Disorders 2
- Biosimilars and Bioanalytical Methods 2
- Co-authors
- Marion Sassier (6 shared papers)Joëlle Micallef (7 shared papers)M. Martin (2 shared papers)Mathieu Puyade (2 shared papers)Ghada Miremont‐Salamé (1 shared paper)Marie‐Christine Pérault‐Pochat (1 shared paper)Nadine Petitpain (2 shared papers)Marc Klein (2 shared papers)
- Journals
- Cancers (1 paper)Scientific Reports (1 paper)Journal of Geriatric Oncology (1 paper)Canadian Journal of Cardiology (1 paper)Drug and Alcohol Dependence (1 paper)
- Partner nations
- FranceNew ZealandSwitzerland
In The Last Decade
Franck Rouby
18 papers receiving 360 citations
Peers
Comparison fields: 5 of 71
- Oncology 216
- Transplantation 16
- Toxicology 16
- Immunology 78
- Nephrology 21
Countries citing papers authored by Franck Rouby
This map shows the geographic impact of Franck Rouby's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Franck Rouby with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Franck Rouby more than expected).
Fields of papers citing papers by Franck Rouby
This network shows the impact of papers produced by Franck Rouby. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Franck Rouby. The network helps show where Franck Rouby may publish in the future.
Co-authors
The 25 scholars most cited alongside Franck Rouby, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 84 | |
| 2 | 2019 | 52 | |
| 3 | 2018 | 41 | |
| 4 | 2019 | 36 | |
| 5 | 2018 | 26 | |
| 6 | 2010 | 23 | |
| 7 | 2021 | 22 | |
| 8 | 2018 | 17 | |
| 9 | 2018 | 15 | |
| 10 | 2018 | 11 | |
| 11 | 2022 | 9 | |
| 12 | 2020 | 8 | |
| 13 | 2021 | 6 | |
| 14 | 2022 | 5 | |
| 15 | 2020 | 4 | |
| 16 | 2008 | 4 | |
| 17 | 2008 | 3 | |
| 18 | 2019 | 2 |
About Franck Rouby
Franck Rouby is a scholar working on Oncology, Immunology, Infectious Diseases, Pharmacology and Pulmonary and Respiratory Medicine, having authored 18 papers that have together received 368 indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (6 papers), Drug-Induced Adverse Reactions (3 papers), Colorectal Cancer Treatments and Studies (2 papers), Pharmacovigilance and Adverse Drug Reactions (2 papers), Melanoma and MAPK Pathways (2 papers), Immunodeficiency and Autoimmune Disorders (2 papers), Biosimilars and Bioanalytical Methods (2 papers) and Pharmaceutical Economics and Policy (2 papers). The work is most often cited by research in Oncology (216 citations), Transplantation (16 citations), Toxicology (16 citations), Immunology (78 citations) and Nephrology (21 citations). Franck Rouby has collaborated with scholars based in France, New Zealand and Switzerland. Frequent co-authors include Marion Sassier, Joëlle Micallef, M. Martin, Mathieu Puyade, Ghada Miremont‐Salamé, Marie‐Christine Pérault‐Pochat, Nadine Petitpain, Marc Klein, Mélissa Yelehe‐Okouma and G. Weryha. Their work appears in journals such as Cancers, Scientific Reports, Journal of Geriatric Oncology, Canadian Journal of Cardiology and Drug and Alcohol Dependence.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.